Colgate-Palmolive (NYSE:CL) Stake Lowered by Radnor Capital Management LLC

Radnor Capital Management LLC cut its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 43.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,003 shares of the company's stock after selling 11,652 shares during the quarter. Radnor Capital Management LLC's holdings in Colgate-Palmolive were worth $1,406,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in CL. Kohmann Bosshard Financial Services LLC bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $26,000. Centricity Wealth Management LLC bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $27,000. Vermillion Wealth Management Inc. bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $31,000. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Finally, Briaud Financial Planning Inc bought a new position in Colgate-Palmolive in the 4th quarter worth approximately $32,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Up 0.0%

NYSE CL opened at $90.18 on Friday. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The company has a market capitalization of $73.08 billion, a PE ratio of 25.62, a price-to-earnings-growth ratio of 4.20 and a beta of 0.38. The firm's fifty day simple moving average is $91.77 and its 200-day simple moving average is $91.19.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.92 billion. During the same period in the prior year, the business posted $0.86 earnings per share. Colgate-Palmolive's revenue for the quarter was down 3.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive declared that its board has authorized a share buyback program on Thursday, March 20th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to purchase up to 6.8% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's management believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were paid a $0.52 dividend. The ex-dividend date of this dividend was Thursday, April 17th. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.31%. Colgate-Palmolive's dividend payout ratio is 58.76%.

Analyst Ratings Changes

CL has been the subject of a number of recent analyst reports. UBS Group increased their price objective on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a report on Thursday, April 17th. JPMorgan Chase & Co. upped their target price on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research report on Monday, April 28th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Citigroup upped their target price on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Finally, Wells Fargo & Company upped their target price on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research report on Wednesday, April 2nd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of "Hold" and a consensus target price of $102.12.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.